Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:AGE

AgeX Therapeutics (AGE) Stock Price, News & Analysis

AgeX Therapeutics logo

About AgeX Therapeutics Stock (NYSE:AGE)

Key Stats

Today's Range
N/A
50-Day Range
$0.22
$16.51
52-Week Range
N/A
Volume
3,700 shs
Average Volume
3,849 shs
Market Capitalization
$11.99 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AGE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AgeX Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AGE Stock News Headlines

URGENT: The Market's 3 Red Flags Are Flashing
Here’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash before 2025 ends.tc pixel
Serina Therapeutics initiated with a Buy at JonesResearch
Serina Therapeutics sells UniverXome subsidiary
Serina Therapeutics Inc (SER)
See More Headlines

AGE Stock Analysis - Frequently Asked Questions

Shares of AgeX Therapeutics split before market open on Monday, March 18th 2024.The 8-5 split was announced on Monday, March 18th 2024. The newly issued shares were issued to shareholders after the market closes on Monday, March 18th 2024. An investor that had 100 shares of stock prior to the split would have 160 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that AgeX Therapeutics investors own include Allena Pharmaceuticals (ALNA), Biocept (BIOC), Aadi Bioscience (AADI), Arbutus Biopharma (ABUS) and Adamis Pharmaceuticals (ADMP).

Company Calendar

Today
10/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NYSE:AGE
CIK
1708599
Employees
5
Year Founded
2017

Profitability

EPS (Trailing Twelve Months)
($13.0282)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$14.80 million
Net Margins
-10,424.65%
Pretax Margin
-10,430.28%
Return on Equity
N/A
Return on Assets
-120.90%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.13
Quick Ratio
0.36

Sales & Book Value

Annual Sales
$140 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($16.07) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
1,080,000
Free Float
1,008,000
Market Cap
$11.99 million
Optionable
Not Optionable
Beta
1.18

Social Links

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NYSE:AGE) was last updated on 10/4/2025 by MarketBeat.com Staff
From Our Partners